| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $0 ) |
| | 2025 | 2022 | ARONORA INC | 1818 SW 4TH AVE | PORTLAND | OR | 97201-5511 | MULTNOMAH | USA | R44HL126235 | Factor XII Inhibitor for Surface Initiated Thrombosis | 000 | 6 | NIH | 10/17/2024 | $0 |
|
| Issue Date FY: 2024 ( Subtotal = $2,643,966 ) |
| | 2024 | 2024 | ARONORA INC | 1818 SW 4TH AVE | PORTLAND | OR | 97201-5511 | MULTNOMAH | USA | R44HL170881 | Contact Pathway Inhibitor to Prevent Catheter-Related Thrombosis | 000 | 1 | NIH | 6/6/2024 | $493,999 |
| | 2024 | 2024 | ARONORA INC | 1818 SW 4TH AVE | PORTLAND | OR | 97201-5511 | MULTNOMAH | USA | R44HL162386 | Thrombopoietin Targeting in Myeloproliferative Neoplasms | 002 | 3 | NIH | 6/27/2024 | $669,111 |
| | 2024 | 2024 | ARONORA INC | 1818 SW 4TH AVE | PORTLAND | OR | 97201-5511 | MULTNOMAH | USA | R44HL167467 | Contact Pathway Inhibitor to Prevent Vascular Access Failure | 000 | 2 | NIH | 6/19/2024 | $1,480,856 |
| | 2024 | 2023 | ARONORA INC | 1818 SW 4TH AVE | PORTLAND | OR | 97201-5511 | MULTNOMAH | USA | R44HL162386 | Thrombopoietin Targeting in Myeloproliferative Neoplasms | 001 | 2 | NIH | 6/14/2024 | $0 |
| | 2024 | 2022 | ARONORA INC | 1818 SW 4TH AVE | PORTLAND | OR | 97201-5511 | MULTNOMAH | USA | R44HL162386 | Thrombopoietin Targeting in Myeloproliferative Neoplasms | 000 | 1 | NIH | 3/21/2024 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $2,698,266 ) |
| | 2023 | 2023 | ARONORA INC | 1818 SW 4TH AVE | PORTLAND | OR | 97201-5511 | MULTNOMAH | USA | R44HL162386 | Thrombopoietin Targeting in Myeloproliferative Neoplasms | 000 | 2 | NIH | 6/25/2023 | $700,302 |
| | 2023 | 2023 | ARONORA INC | 1818 SW 4TH AVE | PORTLAND | OR | 97201-5511 | MULTNOMAH | USA | R44HL167467 | Contact Pathway Inhibitor to Prevent Vascular Access Failure | 001 | 1 | NIH | 6/21/2023 | $0 |
| | 2023 | 2023 | ARONORA INC | 1818 SW 4TH AVE | PORTLAND | OR | 97201-5511 | MULTNOMAH | USA | R44HL167467 | Contact Pathway Inhibitor to Prevent Vascular Access Failure | 000 | 1 | NIH | 5/24/2023 | $998,549 |
| | 2023 | 2023 | ARONORA INC | 1818 SW 4TH AVE | PORTLAND | OR | 97201-5511 | MULTNOMAH | USA | R44HL147695 | Antithrombotic Protein C Activator for Hemodialysis | 000 | 5 | NIH | 5/9/2023 | $999,415 |
| | 2023 | 2020 | ARONORA INC | 1818 SW 4TH AVE | PORTLAND | OR | 97201-5511 | MULTNOMAH | USA | R43AR077473 | E-WE thrombin for prevention of post-traumatic osteoarthritis | 000 | 1 | NIH | 11/2/2022 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $2,254,695 ) |
| | 2022 | 2022 | ARONORA, INC | 1818 SW 4TH AVE STE 102 | PORTLAND | OR | 97201-5511 | MULTNOMAH | USA | R44HL162386 | Thrombopoietin Targeting in Myeloproliferative Neoplasms | 000 | 1 | NIH | 4/22/2022 | $301,788 |
| | 2022 | 2022 | ARONORA, INC | 1818 SW 4TH AVE STE 102 | PORTLAND | OR | 97201-5511 | MULTNOMAH | USA | R44HL147695 | Antithrombotic Protein C Activator for Hemodialysis | 000 | 4 | NIH | 4/30/2022 | $999,415 |
| | 2022 | 2022 | ARONORA INC | 1818 SW 4TH AVE | PORTLAND | OR | 97201 | MULTNOMAH | USA | R44HL126235 | Factor XII Inhibitor for Surface Initiated Thrombosis | 000 | 6 | NIH | 5/20/2022 | $953,492 |
|
| Issue Date FY: 2021 ( Subtotal = $1,980,299 ) |
| | 2021 | 2021 | ARONORA, INC | 4640 SW MACADAM AVE STE 200A | PORTLAND | OR | 97239-4232 | MULTNOMAH | USA | R44HL147695 | Antithrombotic Protein C Activator for Hemodialysis | 000 | 3 | NIH | 3/26/2021 | $998,345 |
| | 2021 | 2021 | ARONORA, INC | 4640 SW MACADAM AVE STE 200A | PORTLAND | OR | 97239-4232 | MULTNOMAH | USA | R44HL126235 | Factor XII Inhibitor for Surface Initiated Thrombosis | 001 | 5 | NIH | 5/19/2021 | $981,954 |
| | 2021 | 2020 | ARONORA, INC | 1818 SW 4TH AVE STE 102 | PORTLAND | OR | 97201-5511 | MULTNOMAH | USA | R44HL147695 | Antithrombotic Protein C Activator for Hemodialysis | 001 | 2 | NIH | 8/9/2021 | $0 |
| | 2021 | 2019 | ARONORA, INC | 1818 SW 4TH AVE STE 102 | PORTLAND | OR | 97201-5511 | MULTNOMAH | USA | R44HL117589 | Therapeutic Protein C Activator for Myocardial Ischemia | 000 | 6 | NIH | 8/17/2021 | $0 |
| | 2021 | 2019 | ARONORA, INC | 1818 SW 4TH AVE STE 102 | PORTLAND | OR | 97201-5511 | MULTNOMAH | USA | R44HL106919 | Factor XI inhibitor for thrombosis | 000 | 6 | NIH | 8/22/2021 | $0 |
| | 2021 | 2018 | ARONORA, INC | 1818 SW 4TH AVE STE 102 | PORTLAND | OR | 97201-5511 | MULTNOMAH | USA | R44HL126235 | Factor XII Inhibitor for Surface Initiated Thrombosis | 000 | 3 | NIH | 2/27/2021 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $2,718,393 ) |
| | 2020 | 2020 | ARONORA, INC | 4640 SW MACADAM AVE STE 200A | PORTLAND | OR | 97239-4232 | MULTNOMAH | USA | R44HL147695 | Antithrombotic Protein C Activator for Hemodialysis | 000 | 2 | NIH | 5/6/2020 | $1,493,466 |
| | 2020 | 2020 | ARONORA, INC | 4640 SW MACADAM AVE STE 200A | PORTLAND | OR | 97239-4232 | MULTNOMAH | USA | R44HL126235 | Factor XII Inhibitor for Surface Initiated Thrombosis | 000 | 4 | NIH | 5/22/2020 | $999,930 |
| | 2020 | 2020 | ARONORA, INC | 4640 SW MACADAM AVE STE 200A | PORTLAND | OR | 97239-4232 | MULTNOMAH | USA | R43AR077473 | E-WE thrombin for prevention of post-traumatic osteoarthritis | 000 | 1 | NIH | 5/15/2020 | $224,997 |
|
| Issue Date FY: 2019 ( Subtotal = $2,992,372 ) |
| | 2019 | 2019 | ARONORA, INC | 4640 SW MACADAM AVE STE 200A | PORTLAND | OR | 97239-4232 | MULTNOMAH | USA | R44HL106919 | Factor XI inhibitor for thrombosis | 000 | 6 | NIH | 7/22/2019 | $999,525 |
| | 2019 | 2019 | ARONORA, INC | 4640 SW MACADAM AVE STE 200A | PORTLAND | OR | 97239-4232 | MULTNOMAH | USA | R44HL117589 | Therapeutic Protein C Activator for Myocardial Ischemia | 000 | 6 | NIH | 3/15/2019 | $998,750 |
| | 2019 | 2019 | ARONORA, INC | 4640 SW MACADAM AVE STE 200A | PORTLAND | OR | 97239-4232 | MULTNOMAH | USA | R44HL147695 | Antithrombotic Protein C Activator for Hemodialysis | 000 | 1 | NIH | 5/13/2019 | $994,097 |
|
| Issue Date FY: 2018 ( Subtotal = $2,961,876 ) |
| | 2018 | 2018 | ARONORA, INC | 4640 SW MACADAM AVE STE 200A | PORTLAND | OR | 97239-4232 | MULTNOMAH | USA | R44HL117589 | Therapeutic Protein C Activator for Myocardial Ischemia | 000 | 5 | NIH | 3/29/2018 | $999,263 |
| | 2018 | 2018 | ARONORA, INC | 4640 SW MACADAM AVE STE 200A | PORTLAND | OR | 97239-4232 | MULTNOMAH | USA | R44HL126235 | Factor XII Inhibitor for Surface Initiated Thrombosis | 000 | 3 | NIH | 6/18/2018 | $963,088 |
| | 2018 | 2018 | ARONORA, INC | 4640 SW MACADAM AVE STE 200A | PORTLAND | OR | 97239-4232 | MULTNOMAH | USA | R44HL106919 | Factor XI inhibitor for thrombosis | 000 | 5 | NIH | 7/5/2018 | $999,525 |
| | 2018 | 2016 | ARONORA, INC | 4640 SW MACADAM AVE STE 200A | PORTLAND | OR | 97239-4232 | MULTNOMAH | USA | R44HL128016 | Therapeutic factor XI blockade for sepsis | 000 | 6 | NIH | 2/1/2018 | $0 |
| | 2018 | 2016 | ARONORA, INC | 4640 SW MACADAM AVE STE 200A | PORTLAND | OR | 97239-4232 | MULTNOMAH | USA | R44HL095315 | Therapeutic Thrombin Analogs | 000 | 7 | NIH | 9/24/2018 | $0 |
|
| Issue Date FY: 2017 ( Subtotal = $2,356,537 ) |
| | 2017 | 2017 | ARONORA, INC | 4640 SW MACADAM AVE STE 200A | PORTLAND | OR | 97239-4232 | MULTNOMAH | USA | R44HL117589 | Therapeutic Protein C Activator for Myocardial Ischemia | 000 | 4 | NIH | 5/8/2017 | $998,107 |
| | 2017 | 2017 | ARONORA, INC | 4640 SW MACADAM AVE STE 200A | PORTLAND | OR | 97239-4232 | MULTNOMAH | USA | R44HL128016 | Therapeutic factor XI blockade for sepsis | 000 | 6 | NIH | 9/13/2017 | $359,659 |
| | 2017 | 2017 | ARONORA, INC | 4640 SW MACADAM AVE STE 200A | PORTLAND | OR | 97239-4232 | MULTNOMAH | USA | R44HL126235 | Factor XII Inhibitor for Surface Initiated Thrombosis | 000 | 2 | NIH | 7/20/2017 | $998,771 |
| | 2017 | 2015 | ARONORA, INC | 4640 SW MACADAM AVE STE 200A | PORTLAND | OR | 97239-4232 | MULTNOMAH | USA | R44HL117589 | Therapeutic Protein C Activator for Myocardial Ischemia | 001 | 3 | NIH | 6/28/2017 | $0 |
|
| Issue Date FY: 2016 ( Subtotal = $2,169,195 ) |
| | 2016 | 2016 | ARONORA LLC | 3500 Sw Bridlemile Ln | Portland | OR | 97221-4037 | MULTNOMAH | USA | R44HL095315 | Therapeutic Thrombin Analogs | 000 | 7 | NIH | 6/16/2016 | $872,549 |
| | 2016 | 2016 | ARONORA, INC | 4640 SW MACADAM AVE STE 200A | PORTLAND | OR | 97239 | MULTNOMAH | USA | R44HL126235 | Factor XII Inhibitor for Surface Initiated Thrombosis | 000 | 1 | NIH | 7/31/2016 | $299,563 |
| | 2016 | 2016 | ARONORA, INC | 4640 SW MACADAM AVE STE 200A | PORTLAND | OR | 97239 | MULTNOMAH | USA | R44HL128016 | Therapeutic factor XI blockade for sepsis | 000 | 6 | NIH | 4/9/2016 | $997,083 |
|
| Issue Date FY: 2015 ( Subtotal = $2,907,740 ) (Continued on the next page) |
| | 2015 | 2015 | ARONORA, INC | 4640 SW MACADAM AVE STE 200A | PORTLAND | OR | 97239 | MULTNOMAH | USA | R44HL128016 | Therapeutic factor XI blockade for sepsis | 000 | 5 | NIH | 3/14/2015 | $999,329 |
|
